928234.fig.003
Figure 3: LDL-R, HMG-CoAR, and ACAT2 protein expression under hyperin treatment. Notes: Lane 1: no-drug control; 2: low dose of hyperin; 3: medium dose of hyperin; 4: high dose of hyperin; 5: Atorvastatin.